Clinical Trials Logo

Leukocytosis clinical trials

View clinical trials related to Leukocytosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06360952 Not yet recruiting - Neutropenia Clinical Trials

A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

Start date: May 31, 2024
Phase:
Study type: Observational

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders. This investigation will include a minimum of 40 sample sets from unique patients.

NCT ID: NCT04323241 Completed - Clinical trials for Cesarean Section Complications

Association of Placenta Removal Method and Postpartum Leucocytosis

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Cesarean delivery is one of the most common major abdominal operation in women worldwide. The incidence of postpartum infection has been estimated to be 1-4% after vaginal delivery and 10-20% after Cesarean delivery. Although it is widely performed, manual removal of the placenta is still a conflicting issue due to the risk of post-partum endometritis. All cesarean patients are randomized according to the removal of placenta from the uterus after childbirth; manually (Group 1) or controlled cord traction without putting fingers inside the uterus (Group 2). The aim of this study is to examine whether there is an association between the method of removal of the placenta and postpartum white blood cell increase in nonanemic, singleton, low-risk group of women with term pregnancies, who underwent elective cesarean delivery under general anesthesia.

NCT ID: NCT04307979 Recruiting - Clinical trials for Inflammatory Response

Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This study will determine whether acute ingestion of a high fat "Bulletproof Coffee" will lead to changes in plasma triglycerides, immune cell function, as well as cognitive function when compared to a black coffee.

NCT ID: NCT02856633 Completed - Hypertension Clinical Trials

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Start date: July 2016
Phase: N/A
Study type: Observational

The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital signs and to detect the health conditions required by the competition.

NCT ID: NCT02762799 Completed - Leucocytosis Clinical Trials

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Start date: July 18, 2016
Phase: Phase 1
Study type: Interventional

BCD-002-1 is 1 phase clinical trial to evaluate pharmacokinetics, pharmacodynamics and safety of single-injection of Leucostim® to healthy volunteers compared to Neupogen®

NCT ID: NCT02302365 Completed - Leukocytosis Clinical Trials

Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

WBCD
Start date: April 2014
Phase:
Study type: Observational

This study is a multicenter, retrospective data collection of routine clinical use with the Spectra Optia® apheresis system for white blood cell depletion.